Gilead Sciences earmarks $11M for hepatitis C prevention
June 4, 2019
Researchers Advance Search For Laboratory Test to Predict Spread of Breast Cancer
June 4, 2019
Show all

How to treat psoriasis at age 65 and beyond 

As your body changes with age, you may need to treat your psoriasis differently. Here’s what you should know if you’re 65 years of age or older.

Psoriasis is a chronic condition, which means you may treat it for life. As your body changes with age, though, you may need to treat psoriasis differently. Once you’ve celebrated your 65th birthday, it may be best to:

  • Take (or apply) a lower dose of medication
  • Change medications
  • Use a different type of treatment

Here are the treatments that board-certified dermatologists recommend for their patients who are 65 or older.

Psoriasis medication you apply to your skin

With proper medical evaluation and guidance, the following topical (applied to the skin) medications may be a treatment option for someone who is 65 or older:

  • Corticosteroid
  • Vitamin D analogues
  • Tazarotene

If you are 65 or older and applying a corticosteroid to your skin, watch for:

  • Thinning skin (skin looks more transparent)
  • Skin bruises or tears more easily
  • Purple spots on your skin
  • Infection (sore with pus)
  • Blood vessels showing up on your skin

Should you see any of these where you apply your psoriasis medication, contact your dermatologist or health care provider.

Is treatment that you apply to the skin right for you?

For this type of treatment to be effective, you must apply the medication as directed. To find out whether you can do this, ask yourself the following questions:

Read on: [wp_colorbox_media url=”” type=”iframe” hyperlink=”How to treat psoriasis at age 65 and beyond “]

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.